MetaCap

MindWalk Holdings Corp. (HYFT)

NASDAQ: HYFTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.6844-0.1139 (-14.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

HYFT stock chart

Technical analysis

Key statistics

All statistics
Market cap
$32.56M
EPS (TTM)
-$0.26
52-week range
0.64 – 2.99
Day range
0.64 – 0.7982
Volume / Avg
693.54K / 257.86K
Beta
—
Next earnings
Dec 21, 2026

52-week range

$0.64$2.99

HYFT stock today

Shares of MindWalk (HYFT) finished lower on Nov 20 at $0.6844, a drop of 14.27% or $0.1139 per share, versus the S&P 500's 3.70% decline. Volume was 2.7x the average at 693.54K shares, a sign of unusually heavy trading. Shares are 77.1% below their 52-week high of $2.99, set on Jan 12, 2026 and 6.9% above the 52-week low of $0.64, near the bottom of the past year's range.

HYFT is down 62.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 59.0%. MindWalk has posted a net loss over the last twelve months (EPS of -$0.26), so its P/E ratio is not meaningful. MindWalk's next earnings report is expected on Dec 21, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About MindWalk

Company profile

MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Jennifer Lynne Bath Ph.D.
Headquarters
Austin, TX
Employees
74

Analyst forecast

Forecast

Consensus (3 analysts)

none

Avg. price target

$4.33+532.67%

  • Strong buy 0
  • Buy 3
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $3.00High $5.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Dec 21, 2026
EPS estimate
$-0.05

HYFT news

All HYFT news

MindWalk peers

Health Care sector
HYFT peer companies
CompanyPrice% ChgMarket capCompare
GRDXGridAI Technologies Corp.3.16-8.41%$32.44Mvs HYFT
FLNAFilana Therapeutics Inc.0.6413+14.52%$32.26Mvs HYFT
ATNMActinium Pharmaceuticals Inc. (Delaware)1.05-1.87%$33.01Mvs HYFT
VERUVeru Inc.1.94-8.06%$33.08Mvs HYFT
CUECue Biopharma Inc.4.15-7.78%$34.69Mvs HYFT
SERSerina Therapeutics Inc.1.12-6.67%$29.76Mvs HYFT
NXTCNextCure Inc.6.45-4.87%$29.53Mvs HYFT
GRCEGrace Therapeutics Inc.1.71-0.58%$35.97Mvs HYFT

Indexes, lists and sector

MindWalk stock FAQ

What is MindWalk's stock price today?

HYFT last traded at $0.6844 as of Nov 20, 4:00 PM EST, down 14.27% on the day. Prices are delayed at least 15 minutes.

Does MindWalk pay a dividend?

No. MindWalk does not currently pay a regular cash dividend.

When is MindWalk's next earnings date?

MindWalk is expected to report earnings on Monday, December 21, 2026. Analysts expect EPS of $-0.05.

Who is MindWalk's CEO?

Dr. Jennifer Lynne Bath Ph.D. is the chief executive officer of MindWalk Holdings Corp., which has about 74 employees.

Has HYFT ever split its stock?

Yes. The most recent HYFT stock split was a 1-for-5 split on Nov 23, 2020, one of 3 splits on record.

What is the HYFT 52-week high?

The 52-week high for HYFT is $2.99 and the 52-week low is $0.64. The stock is currently 77.1% below its high.

Compare HYFT